Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 17.230 | 17.230 | 0.000 |
Shares | 84.670 | 84.670 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 14.928 | 12.705 |
Price to Book | 2.112 | 1.972 |
Price to Sales | 3.604 | 1.854 |
Price to Cash Flow | 13.407 | 8.730 |
Dividend Yield | 0.480 | 2.605 |
5 Years Earnings Growth | 8.389 | 15.065 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 99.770 | 13.664 |
Communication Services | 0.130 | 16.128 |
Financial Services | 0.070 | 11.839 |
Consumer Cyclical | 0.030 | 20.111 |
Number of long holdings: 47
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Hansoh Pharmaceutical Group | KYG549581067 | 10.72 | 18.52 | +1.42% | |
Sichuan Kelun Biotech | CNE1000062J1 | 10.10 | 168.00 | -4.27% | |
Keymed Biosciences Inc | - | 9.41 | - | - | |
Hutchison China | KYG4672N1198 | 9.27 | 278.00 | -1.07% | |
Remegen | CNE1000048G6 | 8.39 | 16.74 | -7.31% | |
Innovent Biologics | KYG4818G1010 | 7.37 | 37.00 | -3.90% | |
Innocare | KYG4783B1032 | 4.62 | 6.16 | -5.52% | |
Beigene | KYG1146Y1017 | 4.08 | 113.80 | -2.65% | |
Akeso | KYG0146B1032 | 3.40 | 72.20 | -1.43% | |
Hua Medicine | KYG4644K1022 | 2.59 | 1.32 | -15.38% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
001668 | 16.18B | 19.42 | 7.28 | - | ||
China Universal Consumer Industries | 13.38B | -4.18 | -14.23 | 13.30 | ||
China Universal Selective Mixed Sec | 9.92B | 11.91 | -12.65 | 10.73 | ||
China Universal CSI 300 Dynamic Str | 5.24B | 11.87 | -1.44 | 8.89 | ||
China Universal Blue Chip Equity Fu | 4.62B | 1.06 | -11.88 | 11.16 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review